Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Alembic Pharmaceuticals LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:533573NSE Symbol: APLLTDP/E(TTM):41.92
ISIN Demat:INE901L01018Div & Yield %:1.05EPS(TTM):24.87
Book Value(Rs):264.278595Market Cap ( Cr.):20493.67Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 6032.635874.065149.005035.415066.894132.55
Excise Duty0.000.000.000.000.000.00
Net Sales6032.635874.065149.005035.415066.894132.55
Other Income 60.75504.883.5451.1483.90134.75
Stock Adjustments 268.5452.36-72.84-19.85160.65176.50
Total Income6361.926431.305079.705066.705311.444443.80
EXPENDITURE :      
Raw Materials 2057.311852.711587.291482.361464.671222.39
Power & Fuel Cost179.67173.32151.19120.50118.3197.43
Employee Cost 1466.571335.911094.821062.30976.13806.37
Other Manufacturing Expenses 388.12327.87357.21324.10344.44291.44
Selling and Administration Expenses 1269.901191.891173.001088.67848.55661.00
Miscellaneous Expenses 38.21519.7648.3128.8226.0737.52
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure5399.785401.464411.824106.753778.173116.15
Operating Profit962.141029.84667.88959.951533.271327.65
Interest 76.4754.4749.0017.0212.9825.19
Gross Profit885.67975.37618.88942.931520.291302.46
Depreciation277.08271.14272.95284.92182.55135.67
Profit Before Tax608.59704.23345.93658.011337.741166.79
Tax105.4737.75-0.80114.46241.20197.39
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.000.000.000.000.000.00
Reported Net Profit503.12666.48346.73543.551096.54969.40
Extraordinary Items 14.190.990.052.815.20-7.06
Adjusted Net Profit488.93665.49346.68540.741091.34976.46
Adjst. below Net Profit 0.003494.430.00-76.31-114.90-51.00
P & L Balance brought forward4160.910.002632.892440.831709.191296.49
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 216.220.00-672.07275.19250.00525.97
P & L Balance carried down4447.814160.913651.692632.882440.831688.92
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %550.00550.00400.00500.00700.00500.00
Earnings Per Share-Unit Curr25.6033.9117.6427.6555.7951.43
Earnings Per Share(Adj)-Unit Curr25.6033.9117.6427.6555.7951.43
Book Value-Unit Curr264.30249.75224.59269.16259.57177.51